For most people affected by drug use problem, there are family members who are affected also. The negative consequence can be more serious when it is a mother who is using drugs.
The cultivation of drugs is a sign of poverty rather than a sign of wealth. Rather than a “war,” the treatment of the drug problem must be approached as development, security and health issues, the panelists of the workshop “Drugs and Development: Punishing the Poor” said.
The 2011 amendment of the Polish drug law was a good first step, but a lot more has to be done to help people dependent on drugs and strengthen the effectiveness of the country's harm reduction efforts.
Сегодня Глобальный фонд для борьбы со СПИДом, туберкулезом и малярией вводит в действие новую модель финансирования, позволяющую укрепить стратегическую составляющую. До 1,9 млн. долл. США в наличии на 2013 и 2014 годы.
The Global Fund to Fight AIDS, Tuberculosis and Malaria has launched a new funding model that allows it to invest more strategically. Up to $1.9 billion may be available for the new funding model's transition period, in 2013 and 2014.
For many decades, the UN has relied on policies based on the prohibitionist drug conventions, that have led to disastrous consequences. With the "Count the Costs" movie series, HCLU is highlighting the devastating negative effects of global prohibition.
The task for this consultant is to develop a “roadmap” of EU institutions and mechanisms that can be used by EHRN, IDPC and others in their advocacy efforts for drug policy reform. The deadline for applications is Friday 8th March 2013.
The Secretary General of the OAS highlights the urgency to analyse the results of drug policies in the Americas and to explore new approaches to strengthen these efforts and make them more effective.
The global pressure for agricultural land, the drug wars and the coup of 2009 have recently increased the human rights abuses in Honduras, especially among indigenous and peasant groups.
The introduction of the Psychoactive Substances Bill is a comprehensive and thoughtful response to what is proving to be one of the biggest challenges to drug policy makers around the world.